Arsenal Growth Equity

Arsenal Growth Equity is a private equity firm specializing in building technology-rich, market-leading healthcare and industrial growth companies. The firm partners with visionary entrepreneurs to build exceptional businesses in the enterprise, commerce/logistics, healthcare, and resource efficiency sectors. Arsenal Growth Equity has raised institutional equity investment funds totaling over $10 billion, completed more than 290 platform and add-on acquisitions, and achieved more than 35 realizations. The firm works with management teams to build strategically important companies with leading market positions, high growth, and high value-add. Arsenal Growth Equity's current portfolio includes companies such as WCG Clinical, Certara, CellCarta, Lumanity, MaxHealth, Hopebridge, Accumen, and OncoHealth. The firm is committed to driving technology enablement and transformation within healthcare, leveraging next-generation innovation and emerging technologies in predictive analytics, artificial intelligence, and digital automation to enhance the development, delivery, and administration of products and services for its healthcare portfolio companies. Arsenal Growth Equity's team brings deep scientific, technical, and domain expertise across the industrials and healthcare sectors, delivering both differential strategic insights and seasoned commercial judgment. The firm leverages its networks of relationships to provide differentiated access and views that are both market-centric and forward-looking. Arsenal Growth Equity's mission is to build high-growth, technology- and innovation-rich companies that are strategically important to their markets, crafting dynamic strategies and building differentiated businesses with enduring value.

Arsenal Growth Equity's investment strategy focuses on partnering with management teams to build companies with leading market positions, high growth, and high value-add. The firm's portfolio companies have led innovation and transformation in the healthcare industry, advancing the practices of clinical research, safety, and regulatory review through its pharma services companies, including WCG Clinical, Certara, CellCarta, and Lumanity. Arsenal Growth Equity's healthcare payer and provider services companies, such as MaxHealth, Hopebridge, Accumen, and OncoHealth, have become standard bearers of innovation in delivering quality care to patients across the country. The firm's commitment to driving technology enablement and transformation within healthcare is evident in its formation of the Digital, AI, and Data Analytics Group, which leverages next-generation innovation and emerging technologies to enhance the development, delivery, and administration of products and services for its healthcare portfolio companies. Arsenal Growth Equity's team brings deep scientific, technical, and domain expertise across the industrials and healthcare sectors, delivering both differential strategic insights and seasoned commercial judgment. The firm leverages its networks of relationships to provide differentiated access and views that are both market-centric and forward-looking. Arsenal Growth Equity's mission is to build high-growth, technology- and innovation-rich companies that are strategically important to their markets, crafting dynamic strategies and building differentiated businesses with enduring value.

Arsenal Growth Equity's commitment to building technology-rich, market-leading healthcare and industrial growth companies is evident in its extensive portfolio and strategic initiatives. The firm's focus on partnering with visionary entrepreneurs to build exceptional businesses in the enterprise, commerce/logistics, healthcare, and resource efficiency sectors has led to the formation of its Digital, AI, and Data Analytics Group. This group leverages next-generation innovation and emerging technologies in predictive analytics, artificial intelligence, and digital automation to enhance the development, delivery, and administration of products and services for its healthcare portfolio companies. Arsenal Growth Equity's team brings deep scientific, technical, and domain expertise across the industrials and healthcare sectors, delivering both differential strategic insights and seasoned commercial judgment. The firm leverages its networks of relationships to provide differentiated access and views that are both market-centric and forward-looking. Arsenal Growth Equity's mission is to build high-growth, technology- and innovation-rich companies that are strategically important to their markets, crafting dynamic strategies and building differentiated businesses with enduring value.